CEACAM5 and colorectal carcinoma: Though the molecular mechanism underlying the CRC's abnormalities is markedly improving which results in more targeted therapy and a decrease in cancer-related mortality recently, Carcinoembryonic antigen (CEA), still was used intensely but with varying results depending on the study design and the study population.